AJP - Heart AJP: Gastrointestinal and Liver Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol (June 12, 2009). doi:10.1152/ajpheart.00312.2009
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
297/2/H726    most recent
00312.2009v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Wang, W.
Right arrow Articles by Muthuchamy, M.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wang, W.
Right arrow Articles by Muthuchamy, M.
Submitted on March 30, 2009
Revised on May 27, 2009
Accepted on June 11, 2009

Inhibition of myosin light chain phosphorylation decreases rat mesenteric lymphatic contractile activity

Wei Wang1, Zhanna Nepiyushchikh1, David C. Zawieja PhD1, Sanjukta Chakraborty1, Scott D Zawieja1, Anatoliy A Gashev2, Michael J. Davis3, and Mariappan Muthuchamy1*

1 Texas A&M Health Science Center College of Medicine
2 Texas A&M HSC
3 University of Missouri

* To whom correspondence should be addressed. E-mail: marim{at}tamu.edu.

The muscular lymphatics use both phasic and tonic contractions to transport lymph for conducting its vital functions. The molecular mechanisms regulating lymphatic muscle contractions are not well understood. Based on the well-established finding that the phosphorylation of myosin light chain 20 (MLC20) plays an essential role in blood vessel smooth muscle contraction, we investigated if MLC20 phosphorylation (pMLC20) would modulate the tonic and/or phasic contractions of lymphatic muscle. The effects of ML-7, a myosin light chain kinase (MLCK) inhibitor (1-10 µM), were tested on the contractile parameters of isolated and cannulated rat mesenteric lymphatics during their responses to the known modulators, pressure (1-5 cm H2O) and substance P (SP, 10-7 M). Immunohistochemical and Western blot analyses of phospho-MLC20 were also performed on isolated lymphatics. The results showed that: 1. Increasing pressure decreased both the lymphatic tonic contraction strength and the pMLC20/MLC20 ratio. 2. SP increased both the tonic contraction strength and the phosphorylation of the MLC20. 3. ML-7 decreased both the lymphatic tonic contraction strength and the pMLC20/MLC20 ratio. 4. The increase in lymphatic phasic contraction frequency in response to increasing pressure is diminished by ML-7; however the phasic contraction amplitude was not significantly altered by ML-7 either in the absence or presence of SP. These data provide the first evidence that tonic contraction strength and phasic contraction amplitude of the lymphatics can be differentially regulated, whereby the increase in MLC20 phosphorylation produces an activation in the tonic contraction without significant changes in phasic contraction amplitude. Thus, tonic contraction of rat mesenteric lymphatics appears to be MLCK-dependent.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 1977 by the American Physiological Society.